Chemed (STU:CXM) Cyclically Adjusted Revenue per Share: €142.73 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CXM Chemed Corp STU:CXM
69 GF Score
Price €436.00
GF Value €599.87
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Chemed Cyclically Adjusted Revenue per Share?

Chemed STU:CXM -1.80% 69 Cyclically Adjusted Revenue per Share is €142.73 as of Jun. 2026. GuruFocus rates STU:CXM with a GF Score™ of 69/100 and a GF Value™ of €599.87 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Chemed's adjusted revenue per share for the three months ended in Jun. 2026 was €43.870. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €142.73 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Chemed's average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Chemed was 14.00% per year. The lowest was -4.00% per year. And the median was 8.60% per year.

As of today (2026-09-16), Chemed's current stock price is €436.00. Chemed's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €142.73. Chemed's Cyclically Adjusted PS Ratio of today is 3.05.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chemed was 5.50. The lowest was 1.88. And the median was 3.98.


Chemed  (STU:CXM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chemed's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=436.00/142.726
=3.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chemed was 5.50. The lowest was 1.88. And the median was 3.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Chemed Cyclically Adjusted Revenue per Share Related Terms


Chemed Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Chemed's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemed Cyclically Adjusted Revenue per Share Chart

Chemed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.97 107.11 116.94 126.85 134.80

Chemed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 133.13 135.04 135.78 139.60 142.73

STU:CXM vs PACS, LFST, CON: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Chemed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemed Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chemed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chemed's Cyclically Adjusted PS Ratio falls into.


STU:CXM
69GF Score
Chemed Corp STU:CXM
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemed Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chemed's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=43.87/333.9520*333.9520
=43.870

Current CPI (Jun. 2026) = 333.9520.

Chemed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 21.245 241.428 29.387
201612 22.543 241.432 31.182
201703 22.665 243.801 31.046
201706 23.558 244.955 32.117
201709 21.328 246.819 28.857
201712 21.686 246.524 29.377
201803 21.161 249.554 28.318
201806 22.058 251.989 29.233
201809 22.768 252.439 30.120
201812 24.052 251.233 31.971
201903 24.624 254.202 32.349
201906 25.623 256.143 33.407
201909 26.111 256.759 33.961
201912 28.480 256.974 37.011
202003 28.348 258.115 36.677
202006 27.853 257.797 36.081
202009 27.623 260.280 35.442
202012 27.362 260.474 35.081
202103 26.844 264.877 33.844
202106 27.442 271.696 33.730
202109 28.844 274.310 35.115
202112 30.509 278.802 36.544
202203 31.130 287.504 36.159
202206 32.991 296.311 37.182
202209 34.747 296.808 39.095
202212 35.626 296.797 40.086
202303 34.552 301.836 38.228
202306 33.436 305.109 36.597
202309 34.139 307.789 37.041
202312 35.688 306.746 38.853
202403 35.393 312.332 37.843
202406 36.292 314.175 38.577
202409 36.379 315.301 38.531
202412 40.020 315.605 42.346
202503 41.635 319.799 43.478
202506 37.131 322.561 38.442
202509 37.111 324.800 38.157
202512 39.207 324.054 40.405
202603 41.053 330.213 41.518
202606 43.870 333.952 43.870

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €142.73 mean?
Chemed (STU:CXM) has a Cyclically Adjusted Revenue per Share of €142.73 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Chemed and its competitors.
Is Chemed's Cyclically Adjusted Revenue per Share too high?
Chemed's current Cyclically Adjusted Revenue per Share is €142.73. Overall, Chemed has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chemed's Cyclically Adjusted Revenue per Share compare to PACS and LFST?
Chemed's Cyclically Adjusted Revenue per Share of €142.73 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Chemed and its competitors. Chemed's current Cyclically Adjusted Revenue per Share is €142.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Based on GuruFocus' analysis, Chemed (STU:CXM) is currently considered Modestly Undervalued. The stock's GF Value™ is €599.87, compared to a current price of €436.00 — trading 27.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €142.73. Chemed's overall GF Score™ is 69/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Chemed (STU:CXM), the current Cyclically Adjusted Revenue per Share is €142.73 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemed (STU:CXM) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of €436.00 is trading 27.3% below its estimated GF Value™ of €599.87. GuruFocus considers Chemed to be Modestly Undervalued.

Key valuation signals for STU:CXM:

  • Cyclically Adjusted Revenue per Share: €142.73
  • GF Value™: €599.87 vs. price of €436.00 (27.3% below fair value)
  • GF Score™: 69/100 with 7 warning signs

No single metric tells the full story. See the STU:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemed Business Description

Other Exchanges CHE:USACXM:Germany
Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
69GF Score

Get the complete analysis for STU:CXM

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€436.00
Price
€599.87
GF Value